MAI Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $947K | Buy |
2,127
+209
| +11% | +$93K | 0.01% | 647 |
|
|
2025
Q1 | $930K | Buy |
1,918
+22
| +1% | +$10.7K | 0.01% | 619 |
|
|
2024
Q4 | $764K | Sell |
1,896
-522
| -22% | -$210K | 0.01% | 699 |
|
|
2024
Q3 | $1.12M | Sell |
2,418
-1,220
| -34% | -$567K | 0.01% | 506 |
|
|
2024
Q2 | $1.71M | Buy |
3,638
+257
| +8% | +$120K | 0.02% | 439 |
|
|
2024
Q1 | $1.41M | Buy |
3,381
+665
| +24% | +$278K | 0.01% | 467 |
|
|
2023
Q4 | $1.11M | Buy |
2,716
+212
| +8% | +$86.3K | 0.01% | 429 |
|
|
2023
Q3 | $871K | Sell |
2,504
-361
| -13% | -$126K | 0.01% | 453 |
|
|
2023
Q2 | $1.01M | Sell |
2,865
-170
| -6% | -$59.8K | 0.01% | 421 |
|
|
2023
Q1 | $956K | Buy |
3,035
+7
| +0.2% | +$2.21K | 0.02% | 425 |
|
|
2022
Q4 | $874K | Buy |
3,028
+470
| +18% | +$136K | 0.01% | 432 |
|
|
2022
Q3 | $741K | Buy |
2,558
+262
| +11% | +$75.9K | 0.01% | 426 |
|
|
2022
Q2 | $647K | Sell |
2,296
-91
| -4% | -$25.6K | 0.01% | 461 |
|
|
2022
Q1 | $623K | Buy |
2,387
+622
| +35% | +$162K | 0.01% | 482 |
|
|
2021
Q4 | $388K | Buy |
1,765
+108
| +7% | +$23.7K | 0.01% | 615 |
|
|
2021
Q3 | $301K | Buy |
+1,657
| New | +$301K | 0.01% | 601 |
|